Rachel Klemovitch, Assistant Editor03.13.24
Integra LifeSciences Corporation released MicroMatrix Flex commercially in the US. MicroMatrix Flex is a dual-syringe system that enables convenient mixing and precise delivery of MicroMatrix paste in hard-to-reach spaces and helps prepare an even wound surface in challenging wound areas.
“We’re excited to be adding MicroMatrix Flex to our market-leading portfolio of dermal matrices,” Steve Powick, senior vice president of Global Marketing, Tissue Technologies Product Division told the press. “This innovation is the culmination of working closely with surgeons to solve meaningful treatment problems and set new standards of care.”
MicroMatrix Flex is designed for managing partial and full-thickness wounds, venous ulcers, pressure ulcers, chronic vascular ulcers, diabetic ulcers, tunned/undermined wounds, trauma wounds, surgical wounds, and draining wounds.
A flexible tip is included in the device to address tunneled, undermined, or irregular wounds. The mixing system produces a paste of flowable consistency to provide contact with all areas of the wound.
“MicroMatrix Flex has allowed me to expand how I use UBM technology in complex wound reconstruction procedures,” commented Dr. Aaron Moore, acute care surgeon, Mercy Health - St. Vincent Medical Center. “In addition to the benefits of UBM technology, the flexible delivery tip addresses the need to access hard-to-reach geometries in complex wounds.”
Dr. Thomas Gilbert, vice president, Research & Development and Process Technology, Tissue Technologies, added “Our UBM technology supports complex wound management, and MicroMatrix Flex allows access to otherwise ‘hidden’ areas of a wound. We developed this innovation through years of research and collaboration. It further expands our comprehensive regenerative medicine offerings across Integra.”
Integra’s UBM products have been used in more than 360,000 procedures over the past decade and UBM has been published in over 200 pre-clinical and clinical publications.
“We’re excited to be adding MicroMatrix Flex to our market-leading portfolio of dermal matrices,” Steve Powick, senior vice president of Global Marketing, Tissue Technologies Product Division told the press. “This innovation is the culmination of working closely with surgeons to solve meaningful treatment problems and set new standards of care.”
MicroMatrix Flex is designed for managing partial and full-thickness wounds, venous ulcers, pressure ulcers, chronic vascular ulcers, diabetic ulcers, tunned/undermined wounds, trauma wounds, surgical wounds, and draining wounds.
A flexible tip is included in the device to address tunneled, undermined, or irregular wounds. The mixing system produces a paste of flowable consistency to provide contact with all areas of the wound.
“MicroMatrix Flex has allowed me to expand how I use UBM technology in complex wound reconstruction procedures,” commented Dr. Aaron Moore, acute care surgeon, Mercy Health - St. Vincent Medical Center. “In addition to the benefits of UBM technology, the flexible delivery tip addresses the need to access hard-to-reach geometries in complex wounds.”
Dr. Thomas Gilbert, vice president, Research & Development and Process Technology, Tissue Technologies, added “Our UBM technology supports complex wound management, and MicroMatrix Flex allows access to otherwise ‘hidden’ areas of a wound. We developed this innovation through years of research and collaboration. It further expands our comprehensive regenerative medicine offerings across Integra.”
Integra’s UBM products have been used in more than 360,000 procedures over the past decade and UBM has been published in over 200 pre-clinical and clinical publications.